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Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilised clinically for the treatment
of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has
successfully been demonstrated to increase MAL-PDT efﬁcacy in an initial clinical pilot study. However,
the biochemical and photochemical processes leading to CP94-enhanced photodynamic cell death, be-
yond the well-documented increases in accumulation of the photosensitiser protoporphyrin IX (PpIX),
have not yet been fully elucidated. This investigation demonstrated that MAL-based photodynamic cell
killing of cultured human squamous carcinoma cells (A431) occurred in a predominantly necrotic
manner following the generation of singlet oxygen and ROS. Augmenting MAL-based photodynamic cell
killing with CP94 co-treatment resulted in increased PpIX accumulation, MitoSOX-detectable ROS gen-
eration (probably of mitochondrial origin) and necrotic cell death, but did not affect singlet oxygen
generation. We also report (to our knowledge, for the ﬁrst time) the detection of intracellular PpIX-
generated singlet oxygen in whole cells via electron paramagnetic resonance spectroscopy in conjunction
with a spin trap.
& 2016 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Photodynamic therapy (PDT) is a relatively selective way to
ablate diseased cells, particularly tumours, without harming nor-
mal surrounding tissues [1]. Successful PDT involves three key
components; pre-administration of a photosensitising agent, de-
livery of light of a speciﬁc wavelength as well as the presence ofB.V. All rights reserved.
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.molecular oxygen [1]. Following photosensitiser accumulation,
and assuming sufﬁcient oxygen levels are present, irradiation of
the target tissue with the activating light leads to the production
of reactive oxygen species (ROS) via Type I and II photochemical
reactions [2]. The production of these reactive species leads to
cellular damage and thus, if produced in sufﬁcient quantities, cell
death [1].
PDT has many applications, including the treatment of bladder,
oesophageal and lung cancers, head and neck lesions and brain
tumours [3,4]. PDT is most commonly used in dermatology to treat
non-melanoma skin cancers and pre-cancers [4]. In dermatological
PDT, one of the most commonly used drugs is methyl-aminole-
vulinate (MAL; Metvixs). As a pro-drug, MAL is enzymatically
converted into the naturally occurring photosensitiser, proto-
porphyrin IX (PpIX), via the haem biosynthesis pathway [5]. An
advantage of using MAL over other non-PpIX inducing photo-
sensitive agents is that it is metabolised quickly, decreasing the
risk of prolonged cutaneous photosensitivity that can be asso-
ciated with other classes of photosensitisers. Furthermore, MAL is
also topically available (being well absorbed into the skin when
applied as a cream formulation) making it a convenient
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The mechanism of cell death induced by MAL-based PDT is not
fully understood. For example, whether cells die primarily through
necrosis or apoptosis and over what time period this occurs has
not been clearly established. Furthermore, in the cell culture
models which are employed to study cell death induced by photo-
irradiation, the observed effects on cell death are dependent on
the protocol and cell type [1]. The generation of ROS during photo-
irradiation of a photosensitiser occurs via Type I and Type II
photochemical reactions [6]. In a biological system, Type I photo-
chemical reactions lead to the production of superoxide anion
radicals (O2), hydrogen peroxide (H2O2) and hydroxyl radicals
(OH), while Type II photochemical reactions lead to the produc-
tion of singlet oxygen (1O2) [1,7–10]. It is well established that the
generation of ROS and 1O2 during photoirradiation of a photo-
sensitiser leads to cellular damage and the initiation of biological
cascades which eventually lead to cell death [11,12].
Due to their short lifetimes, the direct measurement of ROS and
free radicals is difﬁcult [13]. Fluorogenic probes are frequently
utilised in an attempt to detect and quantify ROS generated in
many different biological systems. However, these probes are
rarely speciﬁc and are often used improperly, leading to the de-
tection of multiple ROS with no way to determine which species
have been detected [14]. Some methods are capable of improving
the speciﬁcity of ﬂuorogenic probes. For example, the detection of
O2 by hydroethidine can be performed by selectively exciting
the O2-speciﬁc product, 2-hydroxyethidium [15]. Despite these
improvements, however, electron paramagnetic resonance (EPR)
spectroscopy is considered the gold standard for detecting ROS
directly and speciﬁcally [16–19]. Typically, a nitrone or nitroso
compound is used to “trap” a free radical, producing a nitroxide
(radical or spin adduct), which possesses stability considerably
greater than that of the parent free radical [16,20,21]. Although
there have been numerous studies in which EPR has been utilised
to detect 1O2 and ROS generated by photosensitisers in a cell-free
system [22–27], there appear to be no reports of the same tech-
niques being used to detect ROS generated by photo-irradiated
PpIX in whole cells.
Attempts to improve PpIX-based PDT have included the use of
iron chelating agents [28]. By chelating free iron, the insertion of
iron into the porphyrin ring of PpIX by ferrochelatase is inhibited,
which in turn leads to increased prodrug-induced PpIX accumu-
lation [29]. The hydroxypyridinone iron chelator, CP94, has also
been used to increase PpIX accumulation within human skin
cancers, leading to signiﬁcant decreases in tumour size following
irradiation [30,31]. Although CP94 has shown success as an en-
hancer of PpIX-induced PDT, the biochemical and photochemical
processes behind this effect have not yet been fully elucidated.
In this study, the effects of CP94 on the generation of 1O2 and
ROS in A431 human epidermoid squamous carcinoma cells treated
with MAL and light have been investigated using EPR spectro-
metry and the ﬂuorogenic probes dihydroethidium and a mi-
tochondria-targeted derivative, MitoSOX. The results reported
here suggest that the increased efﬁcacy of MAL-based photo-
dynamic cell killing performed in conjunction with CP94 iron
chelation is, at least in part, due to an increased generation of ROS,
likely localised to the mitochondria.2. Materials and methods
2.1. Chemicals and cells
All reagents were purchased from Sigma-Aldrich Chemical
Company (Poole, UK) unless otherwise stated. A431 (human epi-
dermoid squamous carcinoma) cells were purchased from theEuropean Collection of Cell Culture (Wiltshire, UK). Under aseptic
conditions in a class II laminar ﬂow cabinet, cells were cultured in
DMEM with 10% (v/v) fetal calf serum, 2% (200 mM) L-glutamine
(Lonza; Wokingham, UK), 2% penicillin (200 U/ml) and strepto-
mycin (200 mg/ml) solution. Cells were grown in 5% CO2 at 37 °C
and left to grow until 70–80% conﬂuent, at which time the cells
were passaged (every 4–5 days).
2.2. Cell treatment and irradiation
Cells were seeded in to T 12.5 cm2 culture ﬂasks (Scientiﬁc
Laboratory Supplies; Nottingham, UK) at a concentration of 5105
cells per ml (1106 per ﬂask) and left to grow in 5% CO2 at 37 °C
until they had reached 80% conﬂuence. The medium was aspirated
and cells were washed with PBS prior to the addition of test so-
lutions. Test solutions containing MAL (500 mM)7 CP94 (150 mM),
MnTBAP (100 mM) or L-histidine (25 mM) were prepared in DMEM
growth media and treatments were carried out for 3 h in 5% CO2 at
37 °C. Following treatment with MAL, all further experimentation
was carried out under reduced light conditions to reduce PpIX
photobleaching. Irradiation of cells was carried out using a ﬁltered
narrow band (630715 nm) Aktilite CL16 LED array lamp (Gal-
derma, Bath, UK). At room temperature, each ﬂask was inverted
and irradiated from above, with the light source 10 cm away from
the cells for 5 min to provide a total dose of 25 J/cm2. Following
irradiation, the test solutions were aspirated and fresh DMEM
growth media was applied and the cells were returned to the in-
cubator (5% CO2; 37 °C).
As a positive control for apoptosis, A431 cells seeded in T
12.5 cm2 ﬂasks were treated with 30 mM etoposide for 20 h. Eto-
poside is a topoisomerase inhibitor which is well-documented to
induce apoptosis [32].
2.3. Assessment of cell death
Cell death was assessed using annexin V-FITC and propidium
iodide in conjunction with a Beckman Coulter Quanta SC ﬂow
cytometer. The data collected were analysed using Cell Lab
Quanta™ software (Beckman Coulter, High Wycombe, UK). Cells
that were only stained with propidium iodide were designated
“necrotic”. Cells that were stained with annexin V-FITC, with or
without propidium iodide staining, were designated “apoptotic”.
For the time course, cell death was assessed at 0, 2, 4, 8, 16 and
20 h post-irradiation. When examining the effects of MnTBAP and
L-histidine, cell death was assessed at 20 h post-irradiation. Cells
were trypsinised, washed twice with PBS and re-suspended in
100 ml ice cold calcium buffer (140 mM NaCl, 4 mM KCl, 0.75 mM
MgCl2, 1.5 mM CaCl2 and 10 mM HEPES) containing 1.25 mg/ml
annexin V-FITC. After 15 min incubation on ice in the dark, 900 ml
of Ca2þ buffer containing 0.04 mg/ml propidium iodide was added
to the cell suspension ready for analysis by ﬂow cytometry.
2.4. Protoporphyrin IX ﬂuorescence measurements
Cells were seeded into a 96 well plate at a concentration of
1105 per ml (2104 per well) and left to adhere overnight in 5%
CO2 at 37 °C. The medium was aspirated and cells were washed
with PBS (Lonza) prior to the addition of test solutions. A range of
concentrations of MAL (0–2000 mM)7150 mM CP94 were pre-
pared in DMEM growth media in reduced light levels. Each con-
centration was tested in triplicate in a minimum of 6 separate
experiments. After 3 h of treatment in 5% CO2 at 37 °C, cells were
washed with PBS twice, after which 100 ml of PBS was added to
each well and protoporphyrin IX ﬂuorescence was measured using
a Pherastar ﬂuorescence plate reader (BMG Labtech; Aylesbury,
UK), utilising a 410 nm excitation wavelength and 630 nm
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(0–2 mM) was also prepared and measured in each plate, allowing
for interpolation of a PpIX concentration.
2.5. Detecting ROS using dihydroethidium
A431 cells were seeded and treated as described above. One
hour prior to irradiation, DHE or MitoSOX was added to each ﬂask
at a ﬁnal concentration of 10 mM or 2.5 mM, respectively. Following
irradiation, each ﬂask was prepared immediately for analysis by
ﬂow cytometry: the cells were trypsinised, washed and suspended
in 1 ml of cold PBS ready for analysis. The ﬂuorescence emission of
the superoxide-speciﬁc oxidation products, 2-OH-Eþ and Mito-2-
OH-Eþ , excited with a ﬁltered xenon lamp (370730 nm) and
emission was monitored at 575710 nm. This method was adapted
from Robinson et al., as a means of detecting the superoxide-
speciﬁc reaction product [15]. As a positive control for DHE and
MitoSOX detection of O2 in our system, A431 cells were treated
with carbonyl cyanide m-chlorophenylhydrazone (CCCP). Cells
were treated with 10 mM CCCP for 2 h, after which 10 mM of DHE or
2.5 mM of MitoSOX was added for 1 h. Cells were prepared for ﬂow
cytometry and analysed as described above.
2.6. Neutrophil separation
Peripheral blood was collected from healthy human volunteers
in 15 ml vacutainer tubes containing 1.5 mg/ml EDTA (Becton-
Dickinson UK Ltd.; Oxford, UK). The blood was layered over
Polymorphprep™ (Axis-Shield; Oslo, Norway) in a 15 ml tube and
centrifuged at 500 g for 35 min. The neutrophil layer was re-
moved using a ﬁne-tipped pipette and then diluted in 0.45% (w/v)
NaCl and centrifuged at 200 g for 5 min. The supernatant was
discarded and the pelleted neutrophils were re-suspended in 5 ml
of water, lysing any contaminating red blood cells, before 5 ml of
0.9% NaCl solution was added to restore osmolality. This step was
repeated until any red blood cell contamination that existed was
removed.
2.7. EPR spectrometry
The EPR spectra of known concentrations of TEMPOL (Axxora
Ltd; Birmingham, UK) were obtained, in order to establish a con-
centration-signal response relationship in our system. By plotting
the area under the curve for each spectrum against the con-
centration of TEMPOL (0–5 mM), a standard curve was produced
with a linear regression coefﬁcient of 40.98 (data not shown).
The spin traps used in this investigation were 4-hydroxy-
2,2,6,6-tetramethylpiperidine (TMP; 1O2 trap) and 5-(diethox-
yphosphoryl)-5-methyl-1-pyrroline-N-oxide (DEPMPO; O2
trap). Prior to experimentation it was necessary to set up a positive
control for both of the spin traps.
As a positive control for DEPMPO trapping of O2 , isolated
human neutrophils were treated with phorbol myristate acetate
(PMA), causing a NADPH-dependent burst of O2 [33,34] which,
in the presence of DEPMPO, leads to the formation of the spin
adduct DEPMPO-OOH. This protocol was adapted from Roubaud
et al. [35]: once the neutrophils had been washed, they were
suspended in 1 ml of PBS (4106 cells/ml) containing glucose
(1 mg/ml), albumin (1 mg/ml) and DTPA (0.1 mM) and stored on
ice until used. PMA (in PBS, 200 ng/ml) was added to the cell
suspension along with DEPMPO (20 mM in PBS) in the absence or
presence of bovine superoxide dismutase (SOD) (400 U/ml). EPR
spectra were acquired at room temperature using a RE1X EPR
spectrometer (Jeol Ltd., Welwyn Garden City, UK). Each sample
was injected into a Jeol quartz WG-LC-11 ﬂat cell and placed into
the EPR spectrometer prior to spectral acquisition. Acquisitionswere carried out at t¼0 min, immediately after the addition of
PMA, and t ¼30 min. The spectral acquisition parameters were:
microwave frequency: 9.45 GHz, microwave power 10 mW, centre
ﬁeld 3362 G, sweep width 150 G, sweep time 100 s, time constant
0.3 s, modulation frequency 100 kHz, modulation width 0.63 G
and average of 3 sweeps.
Pre-synthesised PpIX was irradiated (630 nm) in the presence
of TMP as a positive control for TMP trapping of 1O2. TMP was
prepared in 100% methanol and diluted in PBS to a ﬁnal con-
centration of 100 mM and pre-synthesised PpIX (20 mM) was
prepared in DMSO. PpIX and TMP were mixed in a 1:1 ratio, giving
ﬁnal concentrations of 50 mM TMP and 10 mM PpIX, injected into
the ﬂat cell and placed in the EPR cavity. A spectrum was acquired
immediately, in the absence of photo-irradiation. The sample was
then irradiated through the irradiation window in the EPR cavity
for 5 min (25 J/cm2) by an Aktilite CL16-LED lamp, after which a
second spectrum was acquired. The spectral acquisition para-
meters were microwave frequency 9.45 GHz, microwave power
4 mW, centre ﬁeld 3360 G, sweep width 50 G, sweep time 100 s,
time constant 1 s, modulation frequency 100 kHz, modulation
width 1.25 G and average of 3 sweeps.
Measurements of 1O2 and O2 generated in A431 cells during
irradiation were carried out following treatment with MAL 7
CP94 as previously described. After 2.5 h of treatment, cells were
also treated with either TMP (50 mM) or DEPMPO (20 mM) for
30 min. Following treatment, the cells were trypsinised, washed
and suspended in PBS to a density of 1106 cells/ml prior to in-
jection into the ﬂat cell. Spectral acquisitions were then carried out
as before, with acquisitions pre- and post-irradiation.3. Results
3.1. MAL-based photodynamic cell killing
Each treatment group (untreated, treatment with MAL and ir-
radiation, and treatment with MAL, CP94 and irradiation) ex-
hibited low amounts of apoptosis (2–3%) at each time point
measured (0–20 h, Fig. 1A), with no statistically signiﬁcant differ-
ence in the extent of apoptosis between each of the treatments,
nor between any of the time points (p40.05, Kruskal-Wallis test).
In contrast, at 20 h, cells treated with the known pro-apoptotic
compound, etoposide, showed 34.275.5% (mean7SD) apoptosis
and 6.471.3% necrosis.
Untreated cells exhibited low amounts of necrosis at each time
point measured, with no signiﬁcant change over the time course of
the experiment (Fig. 1A). When A431 cells were treated with MAL
and irradiation, a time-dependent increase in necrosis was ob-
served, with 9% necrosis at 4 h post-irradiation, 14.271.6%, at
8 h and 22.571.1% at 20 h.
Following treatment with MAL, CP94 and irradiation, the per-
centage of necrosis increased 2 h post-irradiation (11.170.9%) and
continued to increase at 4 h (15.570.7%), 8 h (18.770.9%), 16 h
(31.471.7%) and 20 h (42.372.4%). At each time point, the per-
centage of necrosis was found to be signiﬁcantly increased over
that of the MAL and irradiation treatment (po0.05, Kruskal-Wallis
test).
3.2. Effects of CP94 on MAL-induced PpIX accumulation in A431 cells
The treatment of A431 cells with MAL resulted in the accu-
mulation of PpIX in a concentration-dependent manner (Fig. 2).
The accumulation of PpIX was signiﬁcantly increased when cells
were concurrently treated with MAL (0.4, 0.5, 1 and 2 mM,
po0.001) and 150 mM CP94 compared with the corresponding
concentration of MAL alone. When treated with MAL-only (2 mM),
Fig. 1. (A) Time-course of cell death induced by MAL (0.5 mM) and irradiation (25 J/cm2) in the absence and presence of CP94 (150 mM) within the A431 cells. The graphs
show the effect of treatment on apoptosis (dashed lines) and necrosis (solid lines), as indicated by annexin V-FITC and propidium iodide staining. Analysis was carried out on
untreated cells (open squares), cells treated with MAL and irradiation (open circles) and MAL, CP94 and irradiation (closed circles). Cells were assessed post-irradiation by
ﬂow cytometry. The data are presented as mean7one standard deviation, n¼9. þ corresponds to po0.05 (Kruskal-Wallis test), comparing untreated cells to cells treated
with a combination of MAL and irradiation and * corresponds to po0.05 comparing untreated cells to cells treated with a combination of MAL, CP94 and irradiation, at each
given time point. (B) Representative contour plots and histograms showing annexin V-FITC and propidium iodide staining of A431 cells following photodynamic cell killing.
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Fig. 2. Concentration-response curves showing the effects of MAL 7 CP94 on PpIX
accumulation. A431 cells were treated with 0 – 2 mM MAL (open circles)7150 mM
CP94 (closed circles) for 3 h, after which PpIX ﬂuorescence was measured (ex: λmax
410 nm, em: λmax 630 nm) and total concentration was interpolated using a stan-
dard curve. Results were normalised by subtracting data for 0 mM MAL from all
data points. Data presented as mean 7 one standard deviation, n¼6. *** corres-
ponds to po0.001 Student's t-test compared to cells treated with MAL.
Fig. 3. Effects of MnTBAP and L-histidine on photodynamic cell killing. A431 cells
were treated with MAL (0.5 mM)7 CP94 (150 mM) and MnTBAP (100 mM) or
L-histidine (25 mM) for 3 h. Following this, cells were irradiated (25 J/cm2) and cell
death was assessed 20 h post-irradiation by annexin V-FITC and propidium iodide
staining in conjunction with ﬂow cytometry. Data are presented as the mean of
total cell death 7 one standard deviation, n¼6. ** corresponds to po0.01, Stu-
dent's t-test compared to untreated (control) cells. þþ corresponds to po0.001
compared to cells treated in the absence of MnTBAP or L-histidine.
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creased peak PpIX accumulation four-fold to 800 nM (po0.001).
3.3. Effects of MnTBAP and L-histidine on photodynamic cell killing
Total cell death was assessed 20 h after photodynamictreatment in the absence and presence of the SOD-mimetic
MnTBAP, or the singlet oxygen quencher L-histidine (Fig 3.).
Background cell death (untreated cells) was 15.570.5%
(mean7SD). Following treatment with MAL and irradiation, cell
death increased to 22.171.8% (po0.01 compared to untreated)
and this increased further to 39.872.6% in cells also treated with
CP94 (po0.01 compared to treatment with MAL and irradiation).
Co-treatment with MnTBAP or L-histidine completely protected
cells from photodynamic cell killing by treatment with the com-
bination of MAL and irradiation (16.371.2% and 16.970.4% re-
spectively, po0.01) which was not signiﬁcantly different from
untreated cells (p¼0.2). MnTBAP and L-histidine also signiﬁcantly
decreased killing of cells treated with MAL, CP94 and irradiation.
Under these conditions, MnTBAP partially protected cells from
photodynamic cell killing (33.471.3%, po0.01) whilst L-histidine
completely protected cells (17.771.5%, po0.01). The high con-
centration of L-histidine (25 mM) used here was found to have no
effect on cell viability when added alone (14.971.2% cell death).
3.4. Dihydroethidium and MitoSOX detection of ROS generated in
cells exposed to MAL-based photodynamic cell killing
DHE and a mitochondria-targeted derivative, MitoSOX, were
used to assess the generation of cytosolic and mitochondria-lo-
calised ROS by PpIX following irradiation. The results, presented in
Fig. 4A and B, are displayed as a percentage of 2-OH-Eþ ﬂuores-
cence detected in untreated (i.e. control) cells (DHE: 100.072.8%,
MitoSOX: 10073.4%). Cells treated with CCCP as a positive control
exhibited a signiﬁcant increase in ﬂuorescence (DHE:
154.9711.7%, MitoSOX: 142.575.0%, po0.01 compared to un-
treated, data not shown). Compared to untreated controls, treat-
ment with MnTBAP alone signiﬁcantly decreased both DHE
ﬂuorescence (90.673.1%) and MitoSOX ﬂuorescence (41.671.4%;
po0.01).
Cells which underwent treatment with MAL and irradiation
also exhibited a signiﬁcant increase in ﬂuorescence (DHE:
156.678.5%, MitoSOX: 192.4712.5%, po0.001 compared to un-
treated) and this increased further in cells which were also treated
with CP94 (DHE: 197.3 11.3%, MitoSOX: 405.3711.5%, po0.001
compared to treatment with MAL and irradiation).
Addition of the SOD-mimetic MnTBAP to all treatments re-
sulted in signiﬁcant decreases in ﬂuorescence. Cells treated with
MAL and irradiation in the presence of MnTBAP exhibited DHE and
MitoSOX ﬂuorescence at 50.570.6% and 69.676.8% of the mean
level observed in the untreated (control) cells (po0.001 compared
to treatment with MAL and irradiation). The cells which were
treated with MAL, CP94 and irradiation in the presence of MnTBAP
exhibited ﬂuorescence of 33.475.9% and 136.673.0% (po0.01
compared to treatment with MAL, CP94 and irradiation).
3.5. EPR detection of ROS generated in cells exposed to MAL-based
photodynamic cell killing
When neutrophils (4106 cells/ml) were stimulated by PMA in
the presence of DEPMPO, the EPR signal observed was that of the
O2 adduct (Fig. 5B), DEPMPO-OOH, with hyperﬁne splitting of:
aN¼13.4 G, aHβ¼11.9 G, aHγ¼0.8 (1 h), 0.43 (6 h) and aP¼52.5 G.
The presence of DTPA prevented the formation of the transition
metal-dependent hydroxyl radical formation, ensuring that the
DEPMPO hydroxyl radical adduct was not formed. In the absence
of PMA, no signal was observed (Fig. 5A) and the addition of active
SOD to PMA-treated neutrophils suppressed the signal completely
(Fig. 5C). When cells were treated with MAL 7 CP94, no DEPMPO-
OOH adduct was detected pre- or post-irradiation (Fig. 5D and E).
Singlet oxygen reacts with the spin trap TMP to form the stable
nitroxide free radical 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy
Fig. 4. Effects of MnTBAP on photo-generated ROS as detected by DHE or MitoSOX. A431 cells were treated with MAL (0.5 mM)7 CP94 (150 mM) and MnTBAP (100 mM) for
3 h. After 2 h, cells were treated with (A) 10 mM DHE or (B) 2.5 mM MitoSOX for 1 h. Following this, cells were irradiated (25 J/cm2) and immediately analysed by ﬂow
cytometry. Data are presented as the mean 7 one standard deviation, n ¼6. ** corresponds to po0.01, Student's t-test compared to untreated (control) cells. þþ
corresponds to po0.001 compared to cells treated in the absence of MnTBAP. (A) 100%¼120.73 RFU, (B) 100%¼100.09 RFU.
Fig. 5. EPR spectra obtained from (A) un-stimulated neutrophils after 30 min,
(B) stimulated neutrophils 30 min after the addition of PMA (200 ng/ml) and
(C) stimulated neutrophils in the presence of SOD (400 U/ml), 30 min after the
addition of PMA. A431 cells were treated with MAL (0.5 mM) and CP94 (150 mM)
and spectra were acquired (D) pre-irradiation (E) and post-irradiation (25 J/cm2).
Each spectrum is representative of 4 repeat experiments. DEPMPO was added to
each condition at a concentration of 20 mM. The spectral acquisition parameters
were: microwave frequency: 9.45 GHz, microwave power 10 mW, centre ﬁeld
3362 G, sweep width 150 G, sweep time 100 s, time constant 0.3 s, modulation
frequency 100 kHz, modulation width 0.63 G and average of 3 sweeps.
Fig. 6. EPR spectra were acquired from pre-synthesised PpIX (10 mM) and TMP
(A) pre-irradiation and (B) post-irradiation (25 J/cm2). Spectrum (C) is re-
presentative of A431 cells treated with TMP only. A431 cells were treated with MAL
(0.5 mM) and spectra were acquired (D) pre-irradiation and (E) post-irradiation.
A431 cells were also treated with MAL and CP94 (150 mM) and spectra were ac-
quired (F) pre-irradiation and (G) post-irradiation. Each spectrum is representative
of 3 repeat experiments. TMP was added to each condition at a concentration of
50 mM. The spectral acquisition parameters were microwave frequency 9.45 GHz,
microwave power 4 mW, centre ﬁeld 3360 G, sweep width 50 G, sweep time 100 s,
time constant 1 s, modulation frequency 100 kHz, modulation width 1.25 G and
average of 3 sweeps.
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When pre-synthesised PpIX and TMP were mixed together in the
absence of irradiation, a very small background signal from the
spin trap was detected (Fig. 6A). However, when the sample was
irradiated the signal increased dramatically (Fig. 6B). The
Fig. 7. Concentrations of TEMPOL formed following spin trapping of photo-
dynamically-generated singlet oxygen by TMP in A431 cells. The average peak area
of each acquired TEMPOL spectrum was determined and concentrations were es-
tablished by interpolating values from a standard curve. Interpolated concentra-
tions of TEMPOL formed following spin trapping of photodynamically-generated
singlet oxygen by TMP in A431 cells. The average peak area of each acquired
TEMPOL spectrum (Fig. 6) was determined and concentrations were established by
interpolating values from a standard curve. *** corresponds to po0.001 (Student's
t-test) compared to cells treated with MAL only. þþþ corresponds to po0.001
compared to cells treated with MAL and CP94.
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1.170.3 mM and this increased to 85.071.9 mM following irra-
diation (po0.001 Student's t-test).
Untreated cells did not produce a detectable concentration of
the TEMPOL adduct (Fig. 6C). Prior to irradiation, cells treated with
MAL produced a small signal, corresponding to a concentration of
0.1470.01 mM TEMPOL (Fig. 6D). Following irradiation, the signal
intensity increased signiﬁcantly to 0.5270.11 mM “TEMPOL
equivalents” (Fig. 6E, po0.001 compared to MAL alone). Treat-
ment with MAL and CP94 in the absence of irradiation produced a
signal equivalent to 0.2370.02 mM TEMPOL (Fig. 6F, po0.001
compared to MAL alone) and irradiation increased this to
0.5170.15 mM TEMPOL equivalents (Fig. 6G, po0.001 compared to
MAL and CP94 dark, p40.05 compared to treatment with MAL
and irradiation). A graphical representation of these values is
shown in Fig. 7.4. Discussion
In the present study, it was observed that CP94 increases the
efﬁcacy of MAL-based photodynamic cell killing in a manner as-
sociated with an increase in O2/ROS, likely localised to the mi-
tochondria. We also report the detection of photo-generated
singlet oxygen in whole cells by EPR spectrometry.
It has previously been shown that the treatment of different
cell types (including A431 cells) with MAL (0.5 mM) and CP94
(150 mM) signiﬁcantly increases accumulation of PpIX compared totreating cells with MAL alone [30]. Here, we have shown that CP94
signiﬁcantly increases PpIX accumulation (3–5 fold) in A431 cells
treated with a range of concentrations of MAL.
The type of photosensitiser, localisation of the photosensitiser
and the dose of light are all important factors in determining the
efﬁcacy of a photodynamic treatment and whether cells will un-
dergo apoptosis or necrosis [3,38,39]. With regard to PpIX-based
photodynamic cell killing, it has previously been shown that ALA-
induced, mitochondria-localised PpIX was far more efﬁcacious
than exogenous, ubiquitously-distributed PpIX when compared at
equivalent concentrations [40]. We have previously demonstrated
that CP94 signiﬁcantly increases the efﬁcacy of MAL-based pho-
todynamic cell killing in a range of human cultured cell types,
more effectively than the more established iron chelator desfer-
rioxamine [41,42] and is effective with all PpIX congeners (ALA,
MAL and HAL (hexaminolevulinate)) and oxygen concentrations
(5%, 20% and 40%) investigated to date [43]. Furthermore these
experimental ﬁndings have translated into greater reductions in
tumour thickness when applied to skin cancers clinically [30,31] as
CP94 is effective as a topical formulation [44]. Here, we have
shown that, following treatment with 0.5 mM MAL and irradiation
(25 J/cm2), A431 cells died primarily by necrosis at each time point
measured, with little more than “background” apoptosis. Necrotic
cell death was also exhibited by cells treated with MAL and CP94
and irradiation and was found to be signiﬁcantly higher at each
time point compared to treatment without CP94. The high levels
of necrosis observed were most likely due to the extensive mi-
tochondrial damage caused by the high concentrations of 1O2 and
ROS being generated [45,46]. Furthermore, the signiﬁcant increase
in necrosis caused by CP94 co-treatment at each time point was
most likely to be the result of further increases in ROS generation
(Fig. 4, discussed below).
The mechanism of action of dermatological PDT is known to be
both intricate and complex and clinical success depends on ade-
quate PpIX accumulation throughout the full thickness of the skin
lesion to be treated, delivery of the complete light dose at the
correct wavelength/time-point in addition to an adequate oxygen
supply being available within the treatment area throughout the
irradiation period [39]. It is also known that lack of PpIX accu-
mulation in the deeper layers of thicker skin tumours (e.g. nodular
basal cell carcinomas) is currently a limiting factor on the clinical
effectiveness of dermatological PpIX-induced PDT.
When considered in detail, the exogenous administration of a
PpIX precursor manipulates neoplastic cells to synthesise and ac-
cumulate PpIX more rapidly than their surrounding normal cells
[1]. This innate haem biosynthesis pathway can also be further
manipulated through the concurrent administration of the iron
chelating agent CP94 to temporarily accumulate elevated amounts
of PpIX to enhance the effectiveness of the PDT treatment. How-
ever as iron can also play a role in the generation of ROS, limiting
its availability through chemical chelation could actually be re-
ducing the efﬁcacy of PpIX-PDT, thus theoretically reducing the
maximal PDT effect that is created. Our previous investigations
considering this possibility however, have concluded that the po-
sitive effects on PDT efﬁcacy produced by increased PpIX accu-
mulation pre-irradiation through the use of the iron chelator CP94,
far outweigh any limitations reduced iron availability may have on
the ability of iron to catalyse ROS generation/cascades following
PpIX-induced PDT [47]. This observation may be explained by al-
ternate transition metals (such as zinc or copper) mediating Fen-
ton-type reactions instead of iron in the subsequent ROS cascades
triggered by PpIX-PDT. Additionally, although cellular iron levels
are usually tightly regulated under normal circumstances, during
oxidative stress iron homeostasis can be disrupted resulting in the
release of labile iron [48,49]. So iron chelation with CP94 may
initially reduce iron availability increasing PpIX accumulation and
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transition metals and freshly released labile iron may perpetuate
the ROS cascades via Fenton reactions [47].
During irradiation, cellular damage is initially caused by the
generation of 1O2 and ROS close to the site of PpIX accumulation
i.e. the mitochondria [50] and the free radical cascades thus in-
itiated, subsequently transmit the damage throughout the cell
generating damage to DNA and other macromolecules [47], which
has been observed following PpIX-PDT 7 CP94. The initial da-
mage to mitochondrial membranes causes release of cytochrome c
and a decrease in cellular ATP. Both of these events occur during
and immediately following irradiation and have been shown to
initiate apoptosis following PpIX-based photodynamic cell killing
in other cell types [51,52]. As time progresses, or if the initial
membrane damage is sufﬁcient, a total loss of ATP production
occurs, a critical step in the switch from apoptosis to necrosis. If
DNA damage occurs, existing ATP can be rapidly depleted by ATP-
dependent poly ADP ribose polymerase (PARP) [53]. Depletion of
ATP results in decreased activity of ATP-dependent Naþ/Kþ and
Ca2þ pumps, leading to increased intracellular Naþ and Ca2þ .
Excessive intracellular Naþ and Ca2þ leads to osmotic damage
[54] and activation of Ca2þ-dependent proteases and nucleases
[55] associated with necrosis. Here, we found that MAL-based
photodynamic cell killing was predominantly necrotic, and that
the addition of CP94 to the MAL-based photodynamic system re-
sulted in further increases in necrotic cell death, with little effect
on apoptosis.
MnTBAP, a superoxide dismutase mimetic, and L-histidine, a
singlet oxygen quencher, were utilised in order to understand the
mechanisms of photodynamic cell killing being induced in this
system. Both MnTBAP and L-histidine inhibited photodynamic
killing in cells treated with MAL, implicating both superoxide and
singlet oxygen as key components in the photodynamic process. In
cells treated with MAL and CP94, MnTBAP partially inhibited
photodynamic cell killing and complete inhibition was achieved by
L-histidine.
Considering these results, we propose that in this system, su-
peroxide is produced by the reduction of singlet oxygen, rather
than being generated directly by excited-state protoporphyrin IX.
Therefore, although superoxide appears to be an important com-
ponent in the photodynamic process, the generation of singlet
oxygen is key to initiate processes that ultimately lead to cell
killing.
Post-irradiation, cells treated with MAL exhibited an increased
EPR signal intensity in the presence of TEMPOL, indicating 1O2
generation within these cells. As far as we know, this is the ﬁrst
time that PpIX-generated 1O2 has been detected in whole cells by
spin trapping with TMP and detection by EPR. A similar TEMPOL
signal was also observed post-irradiation in cells treated with MAL
and CP94. However, the signal intensity was not signiﬁcantly dif-
ferent compared to treatment in the absence of CP94. This was
unexpected: the measurements of PpIX accumulation and cell
death indicated that an increase in 1O2 generation would also be
observed, as photosensitiser concentration is thought to be closely
linked to the amount of 1O2 generated [56,57], which in turn af-
fects the degree and type of cell death induced [58]. The lack of a
detectable difference in TEMPOL signals may be due to an absence
of any changes in 1O2 generation, or a limitation of the method
used for 1O2 detection in this system, such as a lack of co-locali-
sation of TMP with the photo-generated 1O2 or the competition of
TMP with local biomolecules. We have reported (Fig. 6A and B) the
formation of high concentrations of 1O2/TMP-derived TEMPOL.
However this was under ideal conditions in a cell-free system and
it is possible that the detection of intracellular 1O2 may be limited.
The trapping of porphyrin-generated 1O2 by TMP has pre-
viously been demonstrated in a cell-free system [59]. The ex situirradiation (λmax 409 nm) of 10 mM porphyrin in the presence of
10 mM TMP resulted in the formation of the 1O2 adduct, TEMPOL.
The authors found that the generation of 1O2 was dependent on
the light-dose from the irradiation source. This investigation was a
good early indication that porphyrins, upon irradiation, could
generate 1O2, which in turn could be trapped by TMP in the ab-
sence of cells. Similar experiments have been performed with a
variety of photosensitisers [9,27,60,61]. However, to our knowl-
edge there has been no documented literature describing the de-
tection of 1O2, by EPR spectrometry, in cells that had been treated
with MAL. The results presented here are therefore novel as they
are the ﬁrst to show that 1O2 is generated intracellularly following
treatment with MAL-PDT and support the in vivo ﬁndings of
Laubach et al. who detected 1O2 produced by ALA-PDT conducted
on the healthy skin of human volunteers via luminescence [62].
These data strongly indicate that type II photochemical reactions
are occurring during the PpIX-based photodynamic treatment.
Our inhibitor studies with MnTBAP indicate that superoxide is
being produced in our system and, in PpIX-based PDT, O2 and /
or OH are known to be produced directly, as well as indirectly
arising from 1O2 [63]. However, there have been very few studies
on the production of O2 or OH by PpIX using DEPMPO in
conjunction with EPR spectrometry, which could potentially pro-
vide a higher degree of speciﬁcity compared to previously used
methods. The DEPMPO-OOH adduct signal was not detected in our
system. This is potentially due to a low concentration of O2
production, compared to 1O2, which may be below the limit of
detection. This may be further exacerbated by localisation issues,
whereby DEPMPO does not co-localise with mitochondria-loca-
lised PpIX in sufﬁcient quantities to produce a detectable signal.
Porphyrin-based photosensitisers have previously been shown
to generate O2 and OH in a cell-free system [64]. Irradiation of
hematoporphyrin, in the presence of DMPO and DTPA resulted in
the formation of the DMPO-OH adduct. Addition of superoxide
dismutase (SOD) signiﬁcantly decreased the DMPO-OH signal, in-
dicating that O2 was being generated, but as the DMPO-OOH
adduct was not detected it was suggested that O2 was rapidly
decaying to OH in this system. The addition of catalase did not
have an effect on the signal intensity, ruling out the role of H2O2
with this type of photosensitiser [64]. However it has previously
been demonstrated in vivo with ALA-induced PpIX-PDT that both
the combination of SOD with catalase or alternatively allopurinol
(an inhibitor of xanthine oxidase) administration, protected
against PDT-induced tissue damage [65]. This indicated that re-
perfusion injury was implicated in the mechanism of action in this
experimental model, a ﬁnding further endorsed by clinical ob-
servations of oxygen saturation, perfusion data and PpIX ﬂuores-
cence changes in human skin cancers and pre-cancers [39]. It is
therefore likely that on irradiation, singlet oxygen and other ROS
are rapidly produced via photochemical reactions, reducing oxy-
gen and ground state PpIX availability (via photochemical con-
sumption and singlet oxygen destruction respectively). The rapid
oxygen consumption could initiate hypoxia and subsequently
trigger hypoxia-induced vasodilation, leading to increased perfu-
sion and an accompanying replenishment (or partial replenish-
ment) of the depleted oxygen supply. Nevertheless, oxygen will
continue to be consumed as long as adequate ground state PpIX
remains to “feed” the cell-damaging PDT reactions [39].
To detect ROS generated by photo-irradiated PpIX, DHE and its
mitochondria-targeted derivative MitoSOX were utilised. The use
of ﬂuorogenic probes sacriﬁces speciﬁcity in exchange for superior
sensitivity compared to EPR spectrometry. DHE was chosen for
this study as it is known that the hydroxylated ethidium analogue
formed is O2-speciﬁc (2-hydroxy ethidium; 2-OH-Eþ). An ad-
ditional advantage of using DHE is that the mitochondria-targeted
derivative, MitoSOX, is available, allowing the detection of
Y. Dogra et al. / Redox Biology 9 (2016) 90–9998wholecell ROS versus mitochondrial ROS generation using the
same detection system. It has previously been shown that the
reaction of DHE and MitoSOX with O2 both yield their corre-
sponding 2-OH-Eþ analogues [66]. In the present system, it is not
instructive to compare the ﬂuorescence intensities of DHE and
MitoSOX directly, as (a) they accumulate to different extents de-
pending on membrane potentials [15] and (b) different con-
centrations have been used. However, we can draw some con-
clusions based on their relative ﬂuorescence compared to their
respective untreated controls. Treatment with MAL and irradiation
led to a signiﬁcant increase in DHE and MitoSOX-derived 2-OH-Eþ
ﬂuorescence. Furthermore, compared to their respective untreated
controls, the MitoSOX-derived ﬂuorescence was observed to be
signiﬁcantly higher when compared to that of DHE, potentially
indicating a higher concentration of mitochondria-localised O2 ,
compared to that present within the cytosol. The addition of CP94
to the treatment resulted in further increases in both DHE and
MitoSOX ﬂuorescence. Again, compared to their respective un-
treated controls, the increase in MitoSOX ﬂuorescence intensity
was signiﬁcantly higher than that of DHE, , which is suggestive of a
larger increase in mitochondria-localised ROS, including O2 . The
addition of MnTBAP, a known superoxide dismutase-mimetic,
decreased the production of DHE and MitoSOX-derived 2-OH-Eþ ,
providing further evidence that O2 was detected in this system.
As the accumulation of MitoSOX within the mitochondria is
dependent on the mitochondrial membrane potential, it is clear
that treatments which disrupt the function of mitochondria may
have an effect on the localising capability of MitoSOX. Never-
theless, MitoSOX has been widely used as a detector of mi-
tochondrial ROS under conditions where the mitochondrial
membrane potential is known to be affected: for example, the
complex I inhibitor rotenone has been shown to decrease mi-
tochondrial membrane potential [67,68] whilst simultaneously
increasing the generation of mitochondria-localised O2 [69] as
measured by MitoSOX [70] and other methods [71,72]. As the ir-
radiation in our system was carried out following pre-treatment
with MitoSOX, the MitoSOX would be present within the mi-
tochondrial matrix at the commencement of irradiation [73] and, if
the mitochondrial membrane potential subsequently decreased
enough to affect the localisation of MitoSOX, we would expect to
see results similar to those obtained with DHE. With this in mind,
we believe that our experiments with MitoSOX tell us that the
source of these ROS is likely to be mitochondrial in nature.
The use of DHE to detect ROS in PpIX-based photodynamic cell
killing of A431 cells has previously been described [74]. Cells were
treated with ALA (1 mM) for 8 h, after which they were irradiated
with a range of light doses (0–45 J/cm2, λmax 630 nm). Detection of
the ﬂuorescent product was carried out by ﬂow cytometry, with
excitation at 488 nm and emission detection at 600720 nm. The
authors reported a light-dose- dependent production of O2 , up
to the highest tested dose of 45 J/cm2.. In the absence of ALA, ir-
radiation did not result in the formation of any ﬂuorescent product
at any light dose. Additionally, the generation of O2 correlated
with cell death, measured 30 min post-irradiation by propidium
iodide staining in conjunction with ﬂow cytometry. Even though
DHE was used to determine the production of “O2”, at the time
of this work being carried out it was not yet known that two
ﬂuorescent products were formed and it is likely that carrying out
the detection using the method described would have resulted in
the detection of ﬂuorescence from both the Eþ and 2-OH-Eþ .
However, the observation that cell death and ROS/O2 generation
are correlated, agrees with the results presented here.
In conclusion, these data indicate that, under the conditions
described here, human skin cancer cells treated with MAL-based
photodynamic cell killing in the absence and presence of the iron
chelating agent CP94 die in a predominantly necrotic manner.Furthermore, the degree of cell death appears to be, in part, de-
pendent on the amount of mitochondria-localised ROS generated
during photoirradiation. O2 may play a key role in the outcome
of PpIX-based photodynamic treatments and CP94-induced in-
creases in efﬁcacy may be partly due to an increase in mitochon-
dria-localised O2 generation.Contributions
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